GliaPharm ^None

GliaPharm is a Swiss biotechnology company that focuses on developing treatments for neurological and psychiatric disorders by targeting glial cells. Their innovative approach aims to sustain and enhance brain metabolism in pathological conditions. The company's vision is to become a leader in developing glial cell targeting agents that act as neuroprotective agents and maintain cognitive functions. They have been working for decades on the role of glial cells in brain function and health to benefit patients with challenging disorders.